Correlation Between Nabriva Therapeutics and Ocuphire Pharma
Can any of the company-specific risk be diversified away by investing in both Nabriva Therapeutics and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nabriva Therapeutics and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nabriva Therapeutics AG and Ocuphire Pharma, you can compare the effects of market volatilities on Nabriva Therapeutics and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nabriva Therapeutics with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nabriva Therapeutics and Ocuphire Pharma.
Diversification Opportunities for Nabriva Therapeutics and Ocuphire Pharma
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Nabriva and Ocuphire is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Nabriva Therapeutics AG and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Nabriva Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nabriva Therapeutics AG are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Nabriva Therapeutics i.e., Nabriva Therapeutics and Ocuphire Pharma go up and down completely randomly.
Pair Corralation between Nabriva Therapeutics and Ocuphire Pharma
If you would invest 113.00 in Ocuphire Pharma on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Ocuphire Pharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 50.0% |
| Values | Daily Returns |
Nabriva Therapeutics AG vs. Ocuphire Pharma
Performance |
| Timeline |
| Nabriva Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nabriva Therapeutics and Ocuphire Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nabriva Therapeutics and Ocuphire Pharma
The main advantage of trading using opposite Nabriva Therapeutics and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nabriva Therapeutics position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.The idea behind Nabriva Therapeutics AG and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |